CompletedNot Applicable

Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial

United States, India451 participantsStarted 2024-08-15

Plain-language summary

The Safe and Fast Radial Hemostasis using Synergistic Strategies (SAFE \& FAST) trial is an interventional study aimed at reducing the incidence of radial artery occlusion (RAO) rebound bleeding, and the required compression time after transradial approach (TRA) procedures, which have become the default access for coronary procedures globally. The hypothesis is that combining lower-dose heparin and radial hemostasis with simultaneous ipsilateral ulnar artery compression could achieve these improved outcomes.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients referred for diagnostic transradial cardiac catheterization
✓. Age ≥ 18 years
✓. Ability to provide written informed consent

Exclusion criteria

✕. Absence of written informed consent
✕. Patients on long-term systemic anticoagulation therapy for a different indication
✕. Patients requiring a heparin dose of greater than 50 units per kilogram before, during, or after the procedure for any reason.
✕. Patients requiring greater than 6 French catheter access

What they're measuring

Rebound bleeding

Timeframe: 24 hours

Radial artery occlusion

Timeframe: 24 hours

Hematoma formation

Timeframe: 24 hours

Trial details

NCT IDNCT06549842

SponsorRegional Hospital of Scranton

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-15

View on ClinicalTrials.gov More Cardiovascular Diseases trials